EE9800037A - Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks - Google Patents

Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Info

Publication number: EE9800037A
Authority: EE; Estonia
Prior art keywords: pct; sulphonylcarbamates; acylsulphonamides; medicament; manufacture
Prior art date: 1995-08-04

Application number

EE9800037A

Other languages

English (en)

Estonian (et)

Inventor

Robert Krause Brian

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-04

Filing date

1996-07-08

Publication date

1998-08-17

1996-07-08 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

1998-08-17 Publication of EE9800037A publication Critical patent/EE9800037A/xx

Links

102000004895 Lipoproteins Human genes 0.000 title 1
108090001030 Lipoproteins Proteins 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 title 1
WZHRJGWXUCLILI-UHFFFAOYSA-N sulfonylcarbamic acid Chemical class OC(=O)N=S(=O)=O WZHRJGWXUCLILI-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 2
125000001624 naphthyl group Chemical group 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
208000006011 Stroke Diseases 0.000 abstract 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
208000037803 restenosis Diseases 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
239000011593 sulfur Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EE9800037A 1995-08-04 1996-07-08 Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks EE9800037A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US303195P	1995-08-04	1995-08-04
PCT/US1996/011366 WO1997005868A1 (en)	1995-08-04	1996-07-08	Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (1)

Publication Number	Publication Date
EE9800037A true EE9800037A (et)	1998-08-17

Family

ID=21703764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9800037A EE9800037A (et)	1995-08-04	1996-07-08	Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks

Country Status (27)

Country	Link
US (1)	US6117909A (de)
EP (1)	EP0841913B1 (de)
JP (1)	JPH11510184A (de)
KR (1)	KR19990036127A (de)
CN (1)	CN1192140A (de)
AT (1)	ATE232097T1 (de)
AU (1)	AU716255B2 (de)
BG (1)	BG63863B1 (de)
CA (1)	CA2221729A1 (de)
CZ (1)	CZ26198A3 (de)
DE (1)	DE69626118T2 (de)
DK (1)	DK0841913T3 (de)
EA (1)	EA002435B1 (de)
EE (1)	EE9800037A (de)
ES (1)	ES2191762T3 (de)
GE (1)	GEP20012511B (de)
HR (1)	HRP960341A2 (de)
HU (1)	HUP9900668A3 (de)
IL (1)	IL122247A0 (de)
NO (1)	NO980466L (de)
NZ (1)	NZ312571A (de)
PL (1)	PL185943B1 (de)
PT (1)	PT841913E (de)
SK (1)	SK12598A3 (de)
UA (1)	UA46030C2 (de)
WO (1)	WO1997005868A1 (de)
ZA (1)	ZA966617B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1584333A3 (de) *	1998-01-28	2009-04-29	Warner-Lambert Company LLC	Verwendung von Acetylcoenzyme A Inhibitoren zur Behandlung von Alzheimer
BR9912296A (pt) *	1998-07-21	2001-04-17	Warner Lambert Co	Co-adminiostração de inibidores acat e mmp para o tratamento de lesões ateroscleróticas
IT1303249B1 (it) *	1998-10-23	2000-11-06	Dompe Spa	Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
CN1414848A (zh) *	1999-11-05	2003-04-30	沃尼尔·朗伯公司	Acat抑制剂对斑块破裂的预防
CA2369967A1 (en) *	2001-02-12	2002-08-12	Joseph Anthony Cornicelli	Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) *	2002-03-12	2005-09-06	Igt	Gaming device having varying risk player selections
EP3709986B1 (de)	2017-11-14	2023-11-01	Merck Sharp & Dohme LLC	Neuartige substituierte biarylverbindungen als indolamin-2,3-dioxygenase(ido)-inhibitoren
BR112020008258B8 (pt)	2017-11-14	2023-01-31	Merck Sharp & Dohme	Compostos de biarila substituída ou seus sais farmaceuticamente aceitáveis, sua composição e seu uso como inibidores de indoleamina 2,3-dioxigenase (ido)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5003106A (en) *	1983-07-19	1991-03-26	American Cyanamid Company	Antiatherosclerotic ureas and thioureas
AU654688B2 (en) *	1990-10-30	1994-11-17	Warner-Lambert Company	Oxysulfonyl carbamates
US5245068A (en) *	1990-10-30	1993-09-14	Warner-Lambert Company	Oxysulfonyl carbamates
IL101785A0 (en) *	1991-05-10	1992-12-30	Fujisawa Pharmaceutical Co	Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) *	1993-05-14	1996-02-13	Warner-Lambert Company	N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) *	1993-05-14	2001-01-11	Warner Lambert Co	Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

1996
- 1996-07-08 CA CA002221729A patent/CA2221729A1/en not_active Abandoned
- 1996-07-08 GE GEAP19964165A patent/GEP20012511B/en unknown
- 1996-07-08 JP JP9508427A patent/JPH11510184A/ja active Pending
- 1996-07-08 AU AU64541/96A patent/AU716255B2/en not_active Ceased
- 1996-07-08 CZ CZ98261A patent/CZ26198A3/cs unknown
- 1996-07-08 CN CN96196033A patent/CN1192140A/zh active Pending
- 1996-07-08 DE DE69626118T patent/DE69626118T2/de not_active Expired - Fee Related
- 1996-07-08 HU HU9900668A patent/HUP9900668A3/hu unknown
- 1996-07-08 PT PT96923687T patent/PT841913E/pt unknown
- 1996-07-08 US US09/000,296 patent/US6117909A/en not_active Expired - Fee Related
- 1996-07-08 ES ES96923687T patent/ES2191762T3/es not_active Expired - Lifetime
- 1996-07-08 PL PL96324908A patent/PL185943B1/pl unknown
- 1996-07-08 AT AT96923687T patent/ATE232097T1/de not_active IP Right Cessation
- 1996-07-08 DK DK96923687T patent/DK0841913T3/da active
- 1996-07-08 EE EE9800037A patent/EE9800037A/xx unknown
- 1996-07-08 IL IL12224796A patent/IL122247A0/xx unknown
- 1996-07-08 SK SK125-98A patent/SK12598A3/sk unknown
- 1996-07-08 NZ NZ312571A patent/NZ312571A/en unknown
- 1996-07-08 WO PCT/US1996/011366 patent/WO1997005868A1/en not_active Ceased
- 1996-07-08 EP EP96923687A patent/EP0841913B1/de not_active Expired - Lifetime
- 1996-07-08 EA EA199800176A patent/EA002435B1/ru not_active IP Right Cessation
- 1996-07-08 KR KR1019980700795A patent/KR19990036127A/ko not_active Ceased
- 1996-07-16 HR HR60/003,031A patent/HRP960341A2/hr not_active Application Discontinuation
- 1996-08-02 ZA ZA9606617A patent/ZA966617B/xx unknown
- 1996-08-07 UA UA97126430A patent/UA46030C2/uk unknown
1998
- 1998-01-30 BG BG102222A patent/BG63863B1/bg unknown
- 1998-02-03 NO NO980466A patent/NO980466L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BG102222A (en)	1998-09-30
UA46030C2 (uk)	2002-05-15
PL185943B1 (pl)	2003-09-30
EA002435B1 (ru)	2002-04-25
PL324908A1 (en)	1998-06-22
IL122247A0 (en)	1998-04-05
HRP960341A2 (en)	1998-02-28
HUP9900668A3 (en)	2000-08-28
CA2221729A1 (en)	1997-02-20
SK12598A3 (en)	1999-02-11
EA199800176A1 (ru)	1998-10-29
HUP9900668A2 (hu)	1999-06-28
DE69626118D1 (de)	2003-03-13
US6117909A (en)	2000-09-12
KR19990036127A (ko)	1999-05-25
NO980466D0 (no)	1998-02-03
WO1997005868A1 (en)	1997-02-20
EP0841913B1 (de)	2003-02-05
EP0841913A1 (de)	1998-05-20
GEP20012511B (en)	2001-08-27
NZ312571A (en)	2000-07-28
CZ26198A3 (cs)	1998-07-15
AU716255B2 (en)	2000-02-24
NO980466L (no)	1998-02-03
ATE232097T1 (de)	2003-02-15
DE69626118T2 (de)	2003-11-27
AU6454196A (en)	1997-03-05
BG63863B1 (bg)	2003-04-30
ZA966617B (en)	1997-02-18
CN1192140A (zh)	1998-09-02
ES2191762T3 (es)	2003-09-16
JPH11510184A (ja)	1999-09-07
DK0841913T3 (da)	2003-05-05
PT841913E (pt)	2003-06-30

Publication	Publication Date	Title
YU32100A (sh)	2003-02-28	Derivati hidrosamske kiseline kao inhibitori matrične metaloproteaze (mmp)
FI943948A0 (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
CO5011115A1 (es)	2001-02-28	Compuestos y metodos quimioquina
ES2133163T3 (es)	1999-09-01	Esteres (o tioesteres) del acido n-acilsulfamico y esteres (o tioesteres) del acido n-sulfonilcarbamico como agentes hipercolesterolemicos.
IS2833B (is)	2013-05-15	1,5 Bensóþíósepín og notkun þeirra gegn fitublæði
ATE218864T1 (de)	2002-06-15	Verwendung von piperidin-derivaten in der behandlung von schizophrenie
DK0759919T3 (da)	1999-07-26	Azolidindioner som antihyperglykæmiske midler
ES2141957T3 (es)	2000-04-01	Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
PT638075E (pt)	2002-06-28	Inibidor da reaccao de maillard
ATE268752T1 (de)	2004-06-15	Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
NO980466L (no)	1998-02-03	Anvendelse av sulfaminsyrederivater, acyl-sulfonamider eller sulfonylkarbamater for fremstilling av et medikament for å redusere lipoproteinnivåer
DE69501359D1 (de)	1998-02-12	Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69227583D1 (de)	1998-12-17	Arylmorpholine, herstellung und verwendung
NO970340D0 (no)	1997-01-27	Organiske forbindelser
DE69616357D1 (de)	2001-11-29	Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
FR2700166B1 (fr)	1995-02-17	Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
MX9709275A (es)	1998-03-29	Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE69227899D1 (de)	1999-01-28	Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
DE69421705D1 (de)	1999-12-23	Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE69816832D1 (de)	2003-09-04	Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
SE9401965D0 (sv)	1994-06-07	New compounds
MXPA04000139A (es)	2004-06-03	Uso de compuestos biciclo para tratar enfermedad de alzheimer.
DE69832796D1 (de)	2006-01-19	Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen